medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2019-5-64-67medsovet-2923Research ArticleКоморбидный пациентComorbid patientВозможности коррекции эндотелиальной дисфункции у пациентов с артериальной гипертензией и ишемической болезнью сердцаPossibilities for correcting endothelial dysfunction in patients with arterial hypertension and coronary heart diseaseФилипповЕ. В.FilippovE. V.

Филиппов Евгений Владимирович – д.м.н., заведующий кафедрой поликлинической терапии и профилактической медицины. 

390013, Россия, г. Рязань, ул. Высоковольтная, д. 9.

Filippov Evgeny Vladimirovich – Dr. of Sci. (Med.), Head of Chair for Polyclinic Therapy and Preventive Medicine. 

390013, Russia, Ryazan, Vysokovoltnaya St., 9. 

dr.philippov@gmail.comФедеральное государственное бюджетное образовательное учреждение высшего образования «Рязанский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения Российской Федерации.РоссияFederal State Budgetary Educational Institution of Higher Education «Ryazan State Medical University named after Academician I.P. Pavlov» of the Ministry of Health of the Russian Federation.Russian Federation201903042019056467Copyright © Филиппов Е.В., 20192019Филиппов Е.В.Filippov E.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/2923

Статья посвящена терапии эндотелиальной дисфункции у пациентов с АГ и ИБС. Дана оценка возможностей коррекции дисфункции эндотелия основными классами антигипертензивных препаратов. Показана эффективность и преимущество комбинированной терапии в лечении таких пациентов.

The article is devoted to the treatment of endothelial  dysfunction in patients with hypertension and coronary artery disease. The authors assess the possibilities for correction of endothelial dysfunction using the main classes of antihypertensive drugs. The efficacy and advantage of combination therapy in the treatment of such patients is shown.

эндотелиальная дисфункцияартериальная гипертензияишемическая болезнь сердцапериндоприламлодипинendothelial dysfunctionarterial hypertensioncoronary heart diseaseperindoprilamlodipineReferencesBonow R.O., Mann D.L., Zipes D.P., Libby P., Brawnwald E. Braunwald’s heart disease: a textbook of cardiovascular medicine: 10th ed., USA, Elsevier 2015. pp. 1943.Bonow R.O., Mann D.L., Zipes D.P., Libby P., Brawnwald E. Braunwald’s heart disease: a textbook of cardiovascular medicine: 10th ed., USA, Elsevier 2015. pp. 1943.Ibrahim M.M., Damasceno A. Hypertension in developing countries. Lancet. 2012;380:611-617.Ibrahim M.M., Damasceno A. Hypertension in developing countries. Lancet. 2012;380:611-617.Lawes C.M., Vander H.S., Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1520.Lawes C.M., Vander H.S., Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1520.Gray L., Lee I.M., Sesso H.D., Batty G.D. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol. 2011;58:2396.Gray L., Lee I.M., Sesso H.D., Batty G.D. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol. 2011;58:2396.Thuillez C., Richard V. Targeting endothelial dysfunction in hypertensive subjects. J Hum Hypertens. 2005;19(Suppl):S21-25.Thuillez C., Richard V. Targeting endothelial dysfunction in hypertensive subjects. J Hum Hypertens. 2005;19(Suppl):S21-25.Hypertension Primer: essential of high blood pressure: basic science, population science, and clinical management. Ed. by J.L. Izzo Jr, D.A. Sica, H.R. Black. 4th ed., 609 p.Hypertension Primer: essential of high blood pressure: basic science, population science, and clinical management. Ed. by J.L. Izzo Jr, D.A. Sica, H.R. Black. 4th ed., 609 p.Филиппов Е.В. Эндотелиальная дисфункция у населения Рязанской области – распространенность и факторы риска (по данным исследования МЕРИДИАН-РО). Российский кардиологический журнал. 2014;11:57–61.Filippov E.V. Endothelial dysfunction in the population of the Ryazan region: the prevalence and risk factors (MERIDIAN-RO study). Rossiyskiy Kardio logicheskiy Zhurnal. 2014;11:57–61. (In Russ).Sciacqua A., Borrello F., Vatrano M., Grembiale R.D., Perticone F. Effect of interaction between left ventricular dysfunction and endothelial function in hypertension. Current Hypertension Reports. 2006;8:212–218.Sciacqua A., Borrello F., Vatrano M., Grembiale R.D., Perticone F. Effect of interaction between left ventricular dysfunction and endothelial function in hypertension. Current Hypertension Reports. 2006;8:212–218.Kitta Y., Obata J.E., Nakamura T., Hirano M., Kodama Y., Fujioka D., Saito Y., Kawabata K., Sano K., Kobayashi T., Yano T., Nakamura K., Kugiyama K. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009 Jan 27;53(4):323-30.Kitta Y., Obata J.E., Nakamura T., Hirano M., Kodama Y., Fujioka D., Saito Y., Kawabata K., Sano K., Kobayashi T., Yano T., Nakamura K., Kugiyama K. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009 Jan 27;53(4):323-30.Li S., Wu Y., Yu G., Xia Q., Xu Y. Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PLoS One. 2014 Mar 3;9(3):e90217.Li S., Wu Y., Yu G., Xia Q., Xu Y. Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PLoS One. 2014 Mar 3;9(3):e90217.Souza-Barbosa L.A., Ferreira-Melo S.E., UbaidGirioli S., Arantes Nogueira E., Yugar-Toledo J.C., et al. Endothelial vascular function in hypertensive patients after renin-angiotensin system blockade. J Clin Hypertens (Greenwich). 2006;8:803–809; quiz 810–801.Souza-Barbosa L.A., Ferreira-Melo S.E., UbaidGirioli S., Arantes Nogueira E., Yugar-Toledo J.C., et al. Endothelial vascular function in hypertensive patients after renin-angiotensin system blockade. J Clin Hypertens (Greenwich). 2006;8:803–809; quiz 810–801.Peller M., Ozierański K., Balsam P., Grabowski M., Filipiak K.J., Opolski G. Influence of betablockers on endothelial function: A meta-analysis of randomized controlled trials. Cardiol J. 2015;22(6):708-16.Peller M., Ozierański K., Balsam P., Grabowski M., Filipiak K.J., Opolski G. Influence of betablockers on endothelial function: A meta-analysis of randomized controlled trials. Cardiol J. 2015;22(6):708-16.Kwang Kon Koh, Quon M.J., Seung Hwan Han, Yonghee Lee, Soo Jin Kim, Yesl Koh, Eak Kyun Shina. Distinct vascular and metabolic effects of different classes of anti-hypertensive drug. Int J Cardiol. 2010 Apr 1;140(1): 73–81Kwang Kon Koh, Quon M.J., Seung Hwan Han, Yonghee Lee, Soo Jin Kim, Yesl Koh, Eak Kyun Shina. Distinct vascular and metabolic effects of different classes of anti-hypertensive drug. Int J Cardiol. 2010 Apr 1;140(1): 73–81Mahajan A.S., Babbar R., Kansal N., Agarwal S.K., Ray P.C. Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension. J Clin Biochem Nutr. 2007 Mar;40(2):141-7.Mahajan A.S., Babbar R., Kansal N., Agarwal S.K., Ray P.C. Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension. J Clin Biochem Nutr. 2007 Mar;40(2):141-7.Mason R.P., Jacob R.F., Corbalan J.J., Kaliszan R., Malinski T.; Amlodipine Increased Endothelial Nitric Oxide and Decreased Nitroxidative Stress Disproportionately to Blood Pressure Changes. American Journal of Hypertension. 2014 March 1;27(Issue 3):482–488.Mason R.P., Jacob R.F., Corbalan J.J., Kaliszan R., Malinski T.; Amlodipine Increased Endothelial Nitric Oxide and Decreased Nitroxidative Stress Disproportionately to Blood Pressure Changes. American Journal of Hypertension. 2014 March 1;27(Issue 3):482–488.Gismondi R.A., Bedirian R., Pozzobon C.R., Ladeira M.C., Oigman W., Neves M.F. Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Dia betics. Arq Bras Cardiol. 2015 Dec;105(6):597-605.Gismondi R.A., Bedirian R., Pozzobon C.R., Ladeira M.C., Oigman W., Neves M.F. Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Dia betics. Arq Bras Cardiol. 2015 Dec;105(6):597-605.Takase S., Matoba T., Nakashiro S., Mukai Y., Inoue S., Oi K., Higo T., Katsuki S., Takemoto M., Suematsu N., Eshima K., Miyata K., Yamamoto M., Usui M., Sadamatsu K., Satoh S., Kadokami T., Hironaga K., Ichi I., Todaka K., Kishimoto J., Egashira K., Sunagawa K. Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial. Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):350-358.Takase S., Matoba T., Nakashiro S., Mukai Y., Inoue S., Oi K., Higo T., Katsuki S., Takemoto M., Suematsu N., Eshima K., Miyata K., Yamamoto M., Usui M., Sadamatsu K., Satoh S., Kadokami T., Hironaga K., Ichi I., Todaka K., Kishimoto J., Egashira K., Sunagawa K. Ezetimibe in Combination With Statins Ameliorates Endothelial Dysfunction in Coronary Arteries After Stenting: The CuVIC Trial (Effect of Cholesterol Absorption Inhibitor Usage on Target Vessel Dysfunction After Coronary Stenting), a Multicenter Randomized Controlled Trial. Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):350-358.Buda V., Andor M., Petrescu L., Cristescu C., Baibata D.E., Voicu M., Munteanu M., Citu I., Muntean C., Cretu O., Tomescu M.C. Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment. Int J Mol Sci. 2017;18(2): 348-359.Buda V., Andor M., Petrescu L., Cristescu C., Baibata D.E., Voicu M., Munteanu M., Citu I., Muntean C., Cretu O., Tomescu M.C. Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment. Int J Mol Sci. 2017;18(2): 348-359.Bertrand M.E. Perindopril/amlodipine combination: an optimal synergy for cardiovascular protection. European Heart Journal Supplements. 2009;11:E22–E25.Bertrand M.E. Perindopril/amlodipine combination: an optimal synergy for cardiovascular protection. European Heart Journal Supplements. 2009;11:E22–E25.Филиппов Е.В. Возможности престанса в коррекции эндотелиальной дисфункции у пациентов с артериальной гипертонией и гипертрофией левого желудочка. Атмосфера. Новости кардиологии. 2017;4:14-19.Filippov E.V. Possibilities of Prestance in the correction of endothelial dysfunction in patients with arterial hypertension and left ventricular hypertrophy. Atmosfera. Novosti Kardiologii. 2017;4:14-19. (In Russ).

The authors declare that there are no conflicts of interest present.